Group 1 - The core event is the establishment of the Xinhua Insurance Running Team, coinciding with the 2025 Beijing Sub-Center Marathon, where Xinhua Insurance serves as the exclusive insurance sponsor [1] - Xinhua Insurance aims to provide comprehensive insurance coverage for 15,000 participants, staff, and volunteers, showcasing its commitment to health protection and urban development [1][2] - The "New Beijing Style·Health Care Travel" service system has been launched, integrating health management, elderly care communities, and travel services, resulting in a 10% year-on-year growth in premium income and a 20% increase in value [2] Group 2 - The "Health Care Travel" platform combines events with health ecology, offering customized health check-ups and elderly community experiences to members of the Xinhua Running Team [2] - The event reflects Xinhua Insurance's integration of corporate culture into social welfare, demonstrating efficient collaboration and meticulous operational capabilities [2] - Customers express appreciation for Xinhua Insurance's service philosophy, noting that the company is redefining its role from risk manager to a promoter of healthy living [3] Group 3 - The marathon serves as a starting point for Xinhua Insurance to deepen its connection with urban development and public welfare through an "insurance + health + sports" model [3] - The company aims to enhance its brand presence and commitment to long-term value through this initiative, reinforcing the slogan "Xinhua Insurance, Long-lasting Protection" [3]

Investment Rating - The report maintains a "Buy-A" investment rating for the company [4][6]. Core Views - The company achieved a record high in 2024 with total revenue of 1325.55 billion yuan, representing a year-on-year increase of 85.3%, and a net profit attributable to shareholders of 262.29 billion yuan, up 201.1% year-on-year [1]. - New business value (NBV) reached 62.53 billion yuan, reflecting a significant year-on-year growth of 106.8% [2]. - The company has prudently adjusted the investment return assumptions for non-linked insurance funds to 4.0% and the risk discount rate to 8.5%, resulting in an embedded value of 2584 billion yuan at the end of 2024, an increase of 3.17% from the beginning of the year [1]. Summary by Sections Business Performance - The company reported original premium income of 1705.11 billion yuan in 2024, a year-on-year increase of 2.8%. Long-term insurance new single premiums were 388.11 billion yuan, down 5.1% year-on-year, while long-term insurance new single regular premiums increased by 15.6% to 272.20 billion yuan [2]. - The new business value rate improved significantly from 6.7% in 2023 to 14.6% in 2024, an increase of 7.9 percentage points [2]. - The personal life insurance business showed a 13-month continuation rate of 95.7%, up 5.9 percentage points year-on-year, and a 25-month continuation rate of 86.2%, up 7.8 percentage points [2]. Agent and Channel Performance - The number of individual insurance agents decreased slightly to 136,000, down by 19,000 year-on-year, but the average monthly performance of agents improved by 41% year-on-year to 0.81 million yuan [3]. - The bancassurance channel generated premium income of 516.74 billion yuan, a year-on-year increase of 8.1%, with first-year premiums for long-term insurance reaching a historical high of 138.73 billion yuan, up 11.5% year-on-year [3]. Investment Performance - Total investment income surged by 251.6% year-on-year, with an overall investment return rate of 5.8%, up 4.0 percentage points year-on-year, and a net investment return rate of 3.2%, down 0.2 percentage points year-on-year [3]. - The proportion of bond investments increased by 2.0 percentage points to 52.1%, while stock investments rose significantly by 70.2% to 1807.95 billion yuan, accounting for 18.8% of total investment assets, an increase of 4.6 percentage points year-on-year [3]. Financial Projections - The report forecasts earnings per share (EPS) for 2025, 2026, and 2027 to be 8.80 yuan, 11.47 yuan, and 11.72 yuan respectively, with a target price of 57.61 yuan based on a 0.65x P/EV for 2025 [4][6].

| A股股票代码：601336 | A股股票简称：新华保险 编号：2025-019号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 关于总精算师任职资格获核准的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 特此公告。 新华人寿保险股份有限公司董事会 2025 年 4 月 1 日 新华人寿保险股份有限公司（以下简称"本公司"）于近日收到国家金融 监督管理总局（以下简称"金融监管总局"）《关于潘兴新华人寿保险股份有 限公司总精算师任职资格的批复》（金复[2025]198号），金融监管总局已核准 潘兴先生担任本公司总精算师的任职资格，潘兴先生总精算师的任职自2025年3 月28日起生效。 潘兴先生的简历请参见本公司于2024年12月28日在上海证券交易所网站 （www.sse.com.cn）发布的《新华保险第八届董事会第二十八次会议决议公告》。 ...

| A股股票代码：601336 | A股股票简称：新华保险 编号：2025-018号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 关于董事任职资格获核准的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"本公司"）于近日收到国家金融监 督管理总局（以下简称"金融监管总局"）《关于毛思雪新华人寿保险股份有限 公司董事任职资格的批复》（金复[2025]190号），金融监管总局已核准毛思雪女 士担任本公司董事的任职资格。 特此公告。 新华人寿保险股份有限公司董事会 2025 年 4 月 1 日 毛思雪女士担任本公司董事的任期自2025年3月26日起至本公司第八届董事 会任期届满时止。毛思雪女士的简历请参见本公司于2024年12月19日在上海证券 交易所网站（www.sse.com.cn）发布的《新华保险2025年第一次临时股东大会会 议材料》。 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年3月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新華人壽保險股份有限公司 呈交日期: 2025年4月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01336 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,034,107,260 | RMB | | 1 | RMB | | 1,034,107,260 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 1,034,107,260 | RMB | | 1 | RMB | | 1,034,107,260 | | 2. ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Insights - The report highlights the strong performance of Xinhua Insurance, with a significant increase in net profit and new business value, making it a recommended asset for investors seeking beta exposure [5][10]. - The company achieved a net profit of 26.23 billion yuan in 2024, representing a year-on-year growth of 201.1%, while new business value reached 6.25 billion yuan, up 106.8% year-on-year [5][10]. Summary by Sections Financial Performance - Xinhua Insurance reported a net profit of 26.23 billion yuan for 2024, a 201.1% increase compared to the previous year [5]. - The new business value for the company was 6.25 billion yuan, reflecting a year-on-year growth of 106.8% [5]. Dividend Policy - The company plans to distribute a dividend of 2.53 yuan per share, which is a substantial increase of 197.6% year-on-year, resulting in a dividend payout ratio of 30.1% [10]. Business Quality and Growth - The company’s premium income reached 170.51 billion yuan, marking a 2.8% increase year-on-year, with a notable improvement in the structure of premium payments [10]. - The first-year premium for long-term insurance increased by 15.6% year-on-year, indicating a positive trend in business quality [10]. Investment Strategy - Xinhua Insurance has increased its allocation to bonds and stocks, enhancing its investment flexibility, with total investment yield rising to 5.8% [10]. - The company’s asset allocation has shifted, with bond exposure increasing from 50.1% to 52.1% and stock exposure rising from 7.9% to 11.1% [10]. Market Position - The report emphasizes Xinhua Insurance's position as a pure life insurance company with the highest equity exposure, making it a leading choice for investors looking for quality beta assets [10].

A 股证券代码：601336 A 股证券简称：新华保险 公告编号：2025-017 号 H 股证券代码： 01336 H 股证券简称：新华保险 新华人寿保险股份有限公司 2025 年第二次临时股东大会决议公告 | 1、出席会议的股东和代理人人数 | | 570 | | --- | --- | --- | | 其中：A | 股股东人数 | 569 | | 境外上市外资股股东人数（H | 股） | 1 | | 2、出席会议的股东所持有表决权的股份总数（股） | | 1,582,337,870 | | 其中：A | 股股东持有股份总数 | 1,387,879,020 | | 境外上市外资股股东持有股份总数（H | 股） | 194,458,850 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | --- | --- | | 份总数的比例（%） | 50.723328 | | 其中：A 股股东持股占股份总数的比例（%） | 44.489767 | | 境外上市外资股股东持股占股份总数的比例（%） | 6.233561 | 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存在任 何虚假记 ...

FANGDA PARTNERS http://www.fangdalaw.com 中国北京市朝阳区光华路一号 电子邮件 E-mail: email@fangdalaw.com 北京嘉里中心北楼 27 层 电 话 Tel.: 86-10-5769-5600 邮政编码：100020 传 真 Fax: 86-10-5769-5788 27/F，North Tower, Beijing Kerry Centre 1 Guanghua Road, Chaoyang District Beijing 100020, PRC 上海市方达（北京）律师事务所 关于新华人寿保险股份有限公司 2025 年第二次临时股东大会的法律意见书 致：新华人寿保险股份有限公司 上海市方达（北京）律师事务所（以下简称"本所"）是具有中华人民共和国 境内法律执业资格的律师事务所。根据相关法律顾问协议，本所指派律师出席新 华人寿保险股份有限公司（以下简称"公司"）2025 年第二次临时股东大会（以下 简称"本次股东大会"），并就本次股东大会的召集和召开程序、参与表决和召集 会议人员的资格、表决程序和表决结果等有关事宜出具本法律意见书。 本法律意见书 ...

基于良好业绩和对股东回报的重视，新华保险拟在2024中期分红基础上，再向全体股东派发2024年末期现金股利每股 1.99元（含税），共计62.08亿元。2024年，新华保险合计拟派发现金股利78.93亿元，占归母净利润的比例超30%，总 额同比增加近200%。 2024年，新华保险连续十年入选了全球最具价值保险品牌的排行榜前五十强，连续13年入榜"财富中国500强"，连续18 年入榜"亚洲品牌500强"，获得穆迪财务实力A2评级，汇誉财务实力A强劲评级。 谈及2025年重点工作时，杨玉成总结了三大方向：一是做改革发展的有为者。继续全面优化体制机制，把改革进行到 底。二是做客户服务的守护者。新华保险把对客户服务上升到战略高度，为客户提供立体式、全方位、全生命周期的 服务。三是要做耐心资本的担当者，切实推动投资板块做大做强。 诚如杨玉成所言，新华保险要"摘得梧桐树，引来金凤凰"，做好新华保险自己，向内求、练内功，把各方面做好，做 全科优等生。 低利率时代应对利差损的三项平衡 在交出超出预期的2024年年报后，新华保险于3月28日召开业绩发布会。 在发布会上，新华保险董事长杨玉成表示，新华保险强化战略转型新动能，2 ...

保险业 买入（维持） 资负共振，净利润增长 201.1% 新华保险（601336）2024 年年报点评 2025 年 3 月 31 日 投资要点： 股价走势 资料来源：iFinD，东莞证券研究所 事件：新华保险发布2024年年报。2024年，新华保险营业收入达1325.55亿元， ◼ 寿险 NBVM 提振 NBV 增长，业务结构持续优化。2024 年，公司实现原保 险保费收入 1,705.11 亿元，同比增长 2.8%。（1）NBVM 提振 NBV 增长。 2024 年，新华保险 2024 年新业务价值 62.53 亿元，同比增长 106.8%； 首年保费口径下新业务价值率 14.6%，较 2023 年的 6.7%提高 7.9 个百分 点。（2）业务结构持续优化。2024 年末长期险首年期交保费占长期险首 年保费比例为 70.1%，较上年同期提升 12.6 个百分点；续期保费占总保 费的比例为 75.0%，"压舱石"作用稳固。新华保险积极抢抓行业复苏发 展机遇，优化产品供给，分红型保险长期险首年保费收入同比大幅增长 本报告的风险等级为中风险。 本报告的信息均来自已公开信息，关于信息的准确性与完整性，建议投资者 ...